GlassScriptPhysician profile
Dale R Mitchell
NPI 1982701926
$3,288.47
in general payments reported to CMS, 2019-2025
33 companies · $698 in 2025
The $698 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $181 · 2021: $58.26 · 2022: $84.35 · 2023: $204 · 2024: $905 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $425.09 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $325.95 | 2023-2025 | |
| Abbvie INC. | $266.51 | 2019-2022 | |
| Pfizer INC. | $261.35 | 2019-2024 | |
| Shield Therapeutics INC | $174.44 | 2023-2025 | Accrufer |
| Dexcom, INC. | $174.04 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $123.22 | 2019-2020 | |
| Biogen, INC. | $110.26 | 2024-2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $108.32 | 2019-2020 | |
| Therapeuticsmd, INC. | $105.09 | 2019-2022 | |
| Evofem Biosciences, INC. | $101.34 | 2024-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $88.04 | 2019-2020 | |
| Allergan, INC. | $87.46 | 2019 | |
| Daiichi Sankyo INC. | $77.43 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.02 | 2019-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $76.39 | 2019-2020 | |
| Organon LLC | $75.01 | 2022-2025 | Nexplanon |
| Mission Pharmacal Company | $67.89 | 2019-2020 | |
| Duchesnay USA Incorporated | $64.91 | 2019 | |
| Avion Pharmaceuticals | $62.12 | 2019-2021 | |
| Roche Diagnostics Corporation | $59.43 | 2019 | |
| Becton, Dickinson and Company | $55.98 | 2024 | Arista Ah Flexitip |
| Hologic Sales and Service, LLC | $47.53 | 2024-2025 | Fetal Fibronectin Enzyme Immunoassay, Acessa Provu System, Novasure |
| Coopersurgical, INC. | $44.14 | 2019-2024 | Paragard T 380a |
| Aspira Women'S Health INC | $41.98 | 2023-2024 | Ova1 |
| Viiv Healthcare Company | $34.12 | 2024 | Apretude |
| Sumitomo Pharma America, INC. | $33.42 | 2024-2025 | Myfembree |
| Amgen INC. | $32.16 | 2023 | Evenity, Prolia |
| Vertical Pharmaceuticals, LLC | $23.28 | 2020 | |
| Radius Health, INC. | $22.68 | 2025 | |
| Ascend Therapeutics US, LLC | $15.00 | 2021 | |
| Minerva Surgical, INC | $14.39 | 2019 | |
| Dysis Medical, INC. | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.